Public library - UKHSA national

UKHSA national

Restricted group | Started - August 2018 | Last activity - September

Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against covid-19 related symptoms in England

Version 1.3 Approved

Document Type: Basic Document
Extension: pdf
Size: 285 KB
Modified: 15/11/21 13:24 by PHE Publishing
Created: 15/11/21 09:13 by PHE Publishing
Ratings: 0

Automatically Extracted Metadata

Format application/pdf; version=1.7

Modified 2021-11-15T13:23:51Z

Creator UKHSA

Created 2021-11-15T13:23:51Z

Language en-GB

Subject COVID-19; coronavirus; BNT162b2; Comirnaty, Pfizer-BioNTech

Title Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against COVID-19 related symptoms in England: test negative case-control study

Content Type application/pdf

Last Modification 2021-11-15T13:23:51Z

Keywords COVID-19; coronavirus; BNT162b2; Comirnaty, Pfizer-BioNTech

Author UKHSA

Creation Date 2021-11-15T13:23:51Z

Save Date 2021-11-15T13:23:51Z

Version 1.3

By PHE Publishing, on 15/11/21 13:24

No Change Log
- Download (285 KB)
- View
Version 1.2

By PHE Publishing, on 15/11/21 09:22

No Change Log
- Download (136 KB)
- View
Version 1.1

By PHE Publishing, on 15/11/21 09:22

No Change Log
- Download (136 KB)
- View
Version 1.0

By PHE Publishing, on 15/11/21 09:13

No Change Log
- Download (137 KB)
- View

Download (285 KB)

Public library - UKHSA national

Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against covid-19 related symptoms in England

Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against covid-19 related symptoms in England

Select whether this is a major or minor version.